Navigation Links
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
Date:10/25/2007

ng pain as measured using the Visual Analogue Scale.

Recent studies in post-operative inflammation have used "clinical cure" at Day 15 as the primary endpoint. In these studies, clinical cure was defined as having 5 anterior chamber cells or less and a flare score of zero. Applying these criteria to our data, at Day 15, 73% of subjects on the difluprednate BID regimen reached clinical cure versus 27% of subjects in the placebo group, for a treatment effect of 46% (p<0.0001). In the difluprednate QID group, 71% of subjects reached clinical cure at Day 15.

Difluprednate was well tolerated with few treatment related adverse events. Of particular note, mean intraocular pressure (IOP) for all study groups remained within the normal range throughout the trial. Three subjects (3%) in the BID group, three subjects (3%) in the QID group, and two subjects (1%) in the placebo group met the criterion for a clinically significant rise in IOP, defined as an increase of greater than 10 mmHg from baseline combined with a peak pressure of more than 21 mmHg at any time point during the study period.

The analysis demonstrated comparable clinical efficacy and acceptable safety profiles for both BID and QID dosing of difluprednate.

"These are extremely robust data," said Dr. Michael Korenfeld, an ophthalmologist with Comprehensive Eye Care in Washington, Missouri who was an investigator in the trial. "Being able to treat ocular inflammatory disease with a more convenient dosing regimen and having the potential to offer rapid resolution of inflammation after ocular surgery would represent a meaningful advance for patients."

"Sirion is very excited about these results. When we started this program, we felt that difluprednate had the potential to be a major step forward in the control of ocular inflammation. These results met our highest expectations" said Barry Butler, President and CEO of Sirion. "We look forward to bringing this important new treatment opti
'/>"/>

SOURCE Sirion Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Sirion Therapeutics Announces Clinical Data to be Presented at the 2007 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
6. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
11. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/z9s8mp/laboratory ) has ... - Global Strategic Business Report" report to ... are provided for the period 2014 through 2020. ... these markets. Market data and analytics are derived ... primarily based on public domain information including company ...
(Date:6/2/2015)... BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) ... Mark A. Sirgo , President and Chief Executive Officer ... Jefferies 2015 Global Healthcare Conference Tuesday, June 2 ... York City , NY The presentation will ... .  For those who are not available to listen to ...
(Date:6/2/2015)... Fla. , June 2, 2015  One hundred ... of Science in Nurse Anesthesia (MSNA) graduates of April ... their first attempt. The graduating class was composed of ... 2015.  The NCE is required of ... Nurse Anesthetist, and graduates of the MSNA program are ...
Breaking Medicine Technology:Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3ADU's Master of Science in Nurse Anesthesia April 2015 Graduates Earn 100 Percent First Time Pass Rate on National Certification Examination 2
... , DURHAM, N.C., Sept. 8 ... formally notified Vatea Fund of the company,s achievement of a milestone ... September 1, 2009. The milestone is a Clinical Trial for Oxycyte ... With the achievement of the milestone, the agreement calls for ...
... BOZEMAN, Mont., Sept 8 LigoCyte Pharmaceuticals, Inc. ... clinical trial of its norovirus vaccine. The Phase I/II ... nasally-delivered, dry powder vaccine in healthy adults. The study will ... by including a live virus challenge of subjects that have ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 2LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 3
(Date:6/2/2015)... On Wednesday, May 27, 2015, professional driver, ... top speed of 207.9 mph. In the process, Hennessey’s ... the 200 mph mark. Jay Leno was on hand ... of Jay Leno’s Garage, which will air on CNBC later ... mile high speed oval at the Continental Tire Proving Grounds ...
(Date:6/2/2015)... Milwaukee, WI (PRWEB) June 02, 2015 ... to announce Lauren Potter from the hit show Glee ... Down Syndrome Awareness Walk in Pleasant Prairie, WI. The ... services for families in Racine, Kenosha, and Walworth counties. ... to have Lauren join us for this important event," ...
(Date:6/2/2015)... Island, N.Y. (PRWEB) June 02, 2015 ... refer to computer generated imagery overlaid on the real ... gone but Vein Visualization, which displays a map of ... shown a steady growth in adoption. , AccuVein, the ... 40% year over year growth rate and such widespread ...
(Date:6/2/2015)... Ahmedabad, Gujarat, India (PRWEB) June 02, 2015 ... a finalist in the 2015 Microsoft Worldwide Small and ... a global field of top Microsoft partners for demonstrating ... on Microsoft technology. , “This comes as no ... expertise are recognized third year consecutively at worldwide level ...
(Date:6/2/2015)... 2015 Did you wish Ryder Weise a ... him, his family isn’t asking for presents, but instead a ... in Saturday’s Cure HHT DC Walk. , Ryder was diagnosed ... malformed blood vessels leading to sudden and extreme bleeding throughout ... Ryder was 3 years old in the form of daily ...
Breaking Medicine News(10 mins):Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2
... for couples lasts from 3 to 13 minutes, contrary ... sexual activity, according to a survey of U.S. and ... and Jenay Guardiani conducted a survey of 50 full ... which include psychologists, physicians, social workers, marriage/family therapists and ...
... By Will Arnett, Matthew Broderick, Steve Carell, Stephen, ... Kevin James,Conan O,Brien, Rosie O,Donnell, Amy Poehler, Adam Sandler, ... The Insult Comic Dog And Many More To Be ... announced today that,Kelsey Grammer, Ben Stiller, Grammy Award-winning band ...
... points to possible weapon against human infection with deadly ... have successfully tested several Ebola vaccines in monkeys and ... for one of the world,s deadliest diseases. , ... We are seeing more and more naturally occurring human ...
... , Montreal, March 31, 2008 A team of ... for a significant fraction of ALS (sporadic amyotrophic lateral sclerosis) ... an incurable neuromuscular disorder that affects motor neurons and leads ... Published in the current online edition of Nature Genetics, the ...
... Md., March 31 The Epilepsy,Foundation,s quick reaction to ... forums raises awareness of the need for Web security ... -- and those who,use its online forums for help, ... who posted rapidly flashing images to cause,serious injury and ...
... first to use a new tool to identify the molecular ... what these microscopic signatures or biomarkers should look like. , ... of Proteome Research, the advance could one day lead to ... as well as other diseases. , With many diseases, the ...
Cached Medicine News:Health News:Good sexual intercourse lasts minutes, not hours, therapists say 2Health News:Kelsey Grammer, Ben Stiller, Maroon 5 and The Roots Added to COMEDY CENTRAL's(R) Live On-air Charity Special 'Night of Too Many Stars: An Overbooked Concert for Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 2Health News:Researchers Successfully Test Ebola Vaccines 2Health News:Researchers identify a gene responsible for cases of Lou Gehrig's disease 2Health News:Epilepsy Foundation Takes Action Against Hackers 2Health News:Scientists: New technique identifies molecular 'biomarkers' for disease 2Health News:Scientists: New technique identifies molecular 'biomarkers' for disease 3
The PC2200h contains two shelves and will hold two PF96hi agitators. It can store 192 random bags (64 apheresis bags)....
The PC3200i has three shelves and will hold three PF96i agitators. Total capacity is 288 random bags (96 apheresis bags)....
... rotators and agitators for continual ... set at 22C (71F) or ... (59F to 104F). Uniformity is ... bottom. Recorder is standard on ...
... incubators hold rotators and agitators ... can be set at 22C ... to 40C (59F to 104F). ... top to bottom. Recorder is ...
Medicine Products: